828 related articles for article (PubMed ID: 9708461)
1. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
Barron HV; Michaels AD; Maynard C; Every NR
J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
[TBL] [Abstract][Full Text] [Related]
2. Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants.
Michaels AD; Maynard C; Every NR; Barron HV
Am J Cardiol; 1999 Nov; 84(10):1176-81. PubMed ID: 10569326
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction.
Shlipak MG; Browner WS; Noguchi H; Massie B; Frances CD; McClellan M
Am J Med; 2001 Apr; 110(6):425-33. PubMed ID: 11331052
[TBL] [Abstract][Full Text] [Related]
4. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
5. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age.
Krumholz HM; Vaccarino V; Ellerbeck EF; Kiefe C; Hennen J; Kresowik TF; Gold JA; Jencks SF; Radford MJ
Am J Cardiol; 1997 Mar; 79(5):581-6. PubMed ID: 9068512
[TBL] [Abstract][Full Text] [Related]
6. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction.
Berger AK; Duval S; Krumholz HM
J Am Coll Cardiol; 2003 Jul; 42(2):201-8. PubMed ID: 12875751
[TBL] [Abstract][Full Text] [Related]
7. Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period.
Martínez M; Agustí A; Arnau JM; Vidal X; Laporte JR
Eur J Clin Pharmacol; 1998 May; 54(3):203-8. PubMed ID: 9681660
[TBL] [Abstract][Full Text] [Related]
8. Trends in long-term management of survivors of acute myocardial infarction by cardiologists in a government university-affiliated teaching hospital.
Mitra S; Findley K; Frohnapple D; Mehta JL
Clin Cardiol; 2002 Jan; 25(1):16-8. PubMed ID: 11808833
[TBL] [Abstract][Full Text] [Related]
9. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.
Kizer JR; Cannon CP; McCabe CH; Mueller HS; Schweiger MJ; Davis VG; Perritt R; Antman EM
Am Heart J; 1999 Jan; 137(1):79-92. PubMed ID: 9878939
[TBL] [Abstract][Full Text] [Related]
10. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
[TBL] [Abstract][Full Text] [Related]
11. Present treatment of acute myocardial infarction in patients over 75 years--data from the Berlin Myocardial Infarction Registry (BHIR).
Schuler J; Maier B; Behrens S; Thimme W
Clin Res Cardiol; 2006 Jul; 95(7):360-7. PubMed ID: 16741630
[TBL] [Abstract][Full Text] [Related]
12. Medication performance measures and mortality following acute coronary syndromes.
Granger CB; Steg PG; Peterson E; López-Sendón J; Van de Werf F; Kline-Rogers E; Allegrone J; Dabbous OH; Klein W; Fox KA; Eagle KA;
Am J Med; 2005 Aug; 118(8):858-65. PubMed ID: 16084178
[TBL] [Abstract][Full Text] [Related]
13. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).
Wu AH; Parsons L; Every NR; Bates ER;
J Am Coll Cardiol; 2002 Oct; 40(8):1389-94. PubMed ID: 12392826
[TBL] [Abstract][Full Text] [Related]
14. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011.
Gitsels LA; Kulinskaya E; Steel N
BMJ Open; 2017 Jan; 7(1):e013570. PubMed ID: 28119386
[TBL] [Abstract][Full Text] [Related]
15. Practical algorithms for pharmacologic management of the post myocardial infarction patient.
Reiffel JA; ;
Clin Cardiol; 2005 Nov; 28(11 Suppl 1):I28-37. PubMed ID: 16450810
[TBL] [Abstract][Full Text] [Related]
16. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment.
Komajda M; Follath F; Swedberg K; Cleland J; Aguilar JC; Cohen-Solal A; Dietz R; Gavazzi A; Van Gilst WH; Hobbs R; Korewicki J; Madeira HC; Moiseyev VS; Preda I; Widimsky J; Freemantle N; Eastaugh J; Mason J;
Eur Heart J; 2003 Mar; 24(5):464-74. PubMed ID: 12633547
[TBL] [Abstract][Full Text] [Related]
17. [Early treatment of acute myocardial infarct: implementation of therapy guidelines in routine clinical practice, MITRA pilot phase].
Schuster S; Koch A; Burczyk U; Schiele R; Wagner S; Zahn R; Glunz HG; Heinrich F; Stuby K; Berg G; Voigtländer T; Gieseler U; Jakob M; Hauptmann P; Senges J
Z Kardiol; 1997 Apr; 86(4):273-83. PubMed ID: 9235799
[TBL] [Abstract][Full Text] [Related]
18. Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function.
Frances CD; Noguchi H; Massie BM; Browner WS; McClellan M
Arch Intern Med; 2000 Sep; 160(17):2645-50. PubMed ID: 10999979
[TBL] [Abstract][Full Text] [Related]
19. Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction.
Krumholz HM; Chen YT; Wang Y; Radford MJ
Arch Intern Med; 2001 Feb; 161(4):538-44. PubMed ID: 11252112
[TBL] [Abstract][Full Text] [Related]
20. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
Fishkind D; Paris BE; Aronow WS
J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
